Biological Therapy for Inflammatory Bowel Disease

The treatment of inflammatory bowel disease (IBD) has posed a major challenge since its appearance. Biomedical researchers, physicians, gastroenterologists, and surgeons have struggled to improve the quality of life of their patients and have sought, above all else, to keep the disease under remissi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Natura: Online
Lingua:inglese
Pubblicazione: IntechOpen 2021
Soggetti:
Accesso online:ONIX_20210420_9781838802646_2696
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1869520350905106432
collection Directory of Open Access Books
description The treatment of inflammatory bowel disease (IBD) has posed a major challenge since its appearance. Biomedical researchers, physicians, gastroenterologists, and surgeons have struggled to improve the quality of life of their patients and have sought, above all else, to keep the disease under remission for as long as possible. Blockers for tumoral necrosis factor alpha (TNF-α) were the first biological drugs to be discovered and for this reason they played a crucial role in the subsequent evolution of IBD treatment. The aim of this book is to provide an overview of such drugs and the latest developments in IBD immunopathology. Our contributors discuss the main indications, efficacy, and possible side effects of the different types of drugs available today for IBD treatment.
format Online
id doab-20.500.12854ir-67337
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher IntechOpen
publisherStr IntechOpen
record_format ojs
spelling doab-20.500.12854ir-673372024-03-31T22:44:14Z Biological Therapy for Inflammatory Bowel Disease Franco Leal, Raquel Torriani, Tristan Gastroenterology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJG Endocrinology The treatment of inflammatory bowel disease (IBD) has posed a major challenge since its appearance. Biomedical researchers, physicians, gastroenterologists, and surgeons have struggled to improve the quality of life of their patients and have sought, above all else, to keep the disease under remission for as long as possible. Blockers for tumoral necrosis factor alpha (TNF-α) were the first biological drugs to be discovered and for this reason they played a crucial role in the subsequent evolution of IBD treatment. The aim of this book is to provide an overview of such drugs and the latest developments in IBD immunopathology. Our contributors discuss the main indications, efficacy, and possible side effects of the different types of drugs available today for IBD treatment. 2021-04-20T16:10:46Z 2021-04-20T16:10:46Z 2020 book ONIX_20210420_9781838802646_2696 9781838802646 9781838802639 9781789859546 https://directory.doabooks.org/handle/20.500.12854/67337 eng image/jpeg n/a https://www.intechopen.com/books https://mts.intechopen.com/storage/books/9078/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/intechopen.83074 10.5772/intechopen.83074 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781838802646 9781838802639 9781789859546 IntechOpen 140 open access
spellingShingle Gastroenterology
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJG Endocrinology
Biological Therapy for Inflammatory Bowel Disease
title Biological Therapy for Inflammatory Bowel Disease
title_full Biological Therapy for Inflammatory Bowel Disease
title_fullStr Biological Therapy for Inflammatory Bowel Disease
title_full_unstemmed Biological Therapy for Inflammatory Bowel Disease
title_short Biological Therapy for Inflammatory Bowel Disease
title_sort biological therapy for inflammatory bowel disease
topic Gastroenterology
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJG Endocrinology
topic_facet Gastroenterology
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJG Endocrinology
url ONIX_20210420_9781838802646_2696